#forecast #market #Alzheimers #therapeutics #expected
PORTLAND, OR, Nov. 06, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global Alzheimer’s therapeutics market was valued at US$6.1 billion in 2021 and is projected to reach US$13 billion by 2031, at a CAGR of 8.1% from 2022 to 2031. The report provides a detailed analysis of the top investment bags, top winning strategies, drivers and opportunities, market size & estimates, competitive landscape, and evolving market trends. The market study is a helpful source of information for frontrunners, newcomers, investors and shareholders to develop strategies for the future and to strengthen their position in the market.
Download free sample report- https://www.alliedmarketresearch.com/request-sample/10900
Report coverage and details:
| report coverage | details |
| forecast period | 2022-2031 |
| base year | 2021 |
| Market size in 2021 | $6.1 billion |
| Market size in 2031 | 13 billion dollars |
| CAGR | 8.1% |
| Number of pages in the report | 310 |
| Covered Segments | drug class,… |
Read on GNW: The forecast market for Alzheimer’s therapeutics is expected
